Dolphin Health Pharmacy

What Dolphin Health Pharmacy does

Dolphin Health Pharmacy (legal entity: Dolphin RX) is an independently owned specialty pharmacy headquartered at 7400 MacArthur Blvd, Suite A, Oakland, CA, operating across California with 11-50 employees. Founded in 2004 by the Patel Family, the company specializes in dispensing and managing specialty medications for patients with complex chronic conditions, with a therapeutic focus on Hepatology (notably Hepatitis C) and Immunology (notably HIV). It serves three primary B2B customer segments: Federally Qualified Health Centers (FQHCs) and 340B-covered clinics, Independent Practice Associations (IPAs) and third-party payers, and medical practices that refer patients for specialty fulfillment. The company holds NABP Healthcare Merchant Accreditation and is positioned as an extension of the clinic workflow rather than a transactional retail dispensary.

The company's core operational methodology is "Precision Prescribing," a three-pronged workflow designed to determine patient acceptance, initiate prior authorizations, or transfer prescriptions to mandated pharmacies within a 24-hour window. Underlying this is proprietary technology developed by its sister company Meditab, including the Dolphin Provider Portal (real-time prescription tracking, document upload, refill authorization, and messaging for providers and patients), a mobile patient application, and claims processing and adjudication systems refined over 20 years of pharmacy operations. The firm also offers Specialty Enrollment Forms (auto-populating digital enrollment packets with ICD-10 and specialty-specific guides), and partners with sister company Elite 340B to deliver 340B program management services including virtual inventory, dispensing, adherence monitoring, and savings reporting.

Dolphin monetizes through multiple revenue streams: transaction-based dispensing fees on specialty prescriptions (with manufacturer, foundation, copay, and coupon financial assistance navigation layered in), managed-services revenue from 340B program partnerships (typically capturing 25-30% medication savings for covered entities), and recurring payer/IPA services for formulary management, prior authorization support, medication therapy management, and data analytics. Go-to-market is enterprise field sales via dedicated Account Managers who build direct relationships with clinics, FQHCs, IPAs, and medical groups across California. The Patel Family has built an ecosystem of approximately 30 independent sister companies spanning pharmacy operations (Vibrant Care Pharmacy for long-term care), technology (Meditab), and 340B management (Elite 340B), creating an unusual vertically integrated structure for a firm of this size.

Name

Dolphin Health Pharmacy

Legal name

Dolphin RX

Website

https://dolphinhealth.com

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

Dolphin Health Pharmacy is an independently owned California specialty pharmacy that dispenses and manages Hepatology and Immunology medications for FQHCs, 340B-covered clinics, IPAs, and medical practices using a proprietary Precision Prescribing workflow, provider portal, and 340B program services.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy Services

NAICS

Pharmacies and Drug Retailers (45611)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

akta.pro secondary industry

Retail & Community Pharmacies (Chain/Independent) (HLAFALAA)

Keywords

• Specialty pharmacy services
• 340B program management
• Hepatology immunology pharmacy
• Prior authorization support
• Pharmacy benefit management

Headquarters

HQ city

Oakland

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Specialty Pharmacy Services: Revenue from dispensing specialty medications to patients with complex or chronic conditions, primarily in Hepatology and Immunology. Services include prior authorization support, eligibility checks, and patient adherence programs. Provides 3-12 days faster therapy initiation compared to competitors.
2. 340B Program Management: Revenue from helping covered entities (FQHCs, hospitals) capture and increase 340B program savings through virtual inventory, dispensing, adherence monitoring, and partnership with Elite 340B for data collection and reporting. Typically captures 25-30% savings on medications.
3. Payer Services & Formulary Management: Services to third-party payers including formulary management, prior authorization support, medication therapy management, and data analytics to help optimize pharmacy benefit plans and control costs.
4. Technology & Form Licensing: Providing customized enrollment forms, checklists, and technology tools to medical practices. Revenue derived from automating precision prescription workflows for partner clinics.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Dolphin Health Pharmacy is an independently owned specialty pharmacy in Oakland, CA that dispenses specialty medications to patients with complex or chronic conditions, primarily in Hepatology and Immunology. The company extends the capabilities of medical practices, FQHCs, IPAs, and hospitals through prescription management, prior authorization support, eligibility checks, adherence programs, 340B program management, and payer pharmacy benefit services, supported by a proprietary provider portal and Precision Prescribing methodology that initiates therapy 3-12 days faster than competitors.

Product overview

Dolphin Health Pharmacy is an independently owned specialty pharmacy offering a unified product portfolio centered on Precision Prescribing—a three-pronged methodology for rapid prescription processing and prior authorization handling. The core technology is the Dolphin Provider Portal, which enables real-time prescription management, document sharing, and pharmacy communication. Supporting modules include 340B Program Services (with Elite 340B partnership for covered entity savings), Payer Services (formulary management and analytics for third-party payers), and Specialty Enrollment Forms (auto-populating specialty-specific forms). The company also offers MyDoses automated dispensing robot for long-term care facilities. All offerings are focused on Hepatology & Immunology patient populations in California.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• Patients on therapy 3-12 days faster than competitors
• +4 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Three partnerships are on record, tiered core and minor.

• Elite 340BcoreStrategic or Co-development PartnerSister company specializing in 340B program data collection, reporting, and savings tracking. Works alongside Dolphin to provide comprehensive 340B program management including virtual inventory, dispensing, and adherence monitoring for covered entities.
• MeditabcoreTechnology or IntegrationTechnology sister company that developed Dolphin's provider portal, mobile application, and automated dispensing robot. Created Intelligent Pharmacy Software (IPS) and Intelligent Medical Software (IMS) used by pharmacies and providers across America. Provides ongoing technology development and support for Dolphin's technology platform.
• Vibrant Care PharmacyminorStrategic or Co-development PartnerSister company providing long-term care facilities with multi-dose blister packaging from patented robot called MyDoses. Part of Patel Family pharmacy network.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Others

• Elite 340B: 340B program management and analytics platform that is actually a Patel Family sister company of Dolphin Health. While not a direct competitor, Elite 340B is the embedded technology and reporting partner for Dolphin's 340B offering and serves as the closest comparable for 340B-only vendors in the FQHC space.

Broad incumbents

• CVS Specialty: Specialty pharmacy arm of CVS Health offering specialty drug dispensing, adherence programs, and 340B-related services through a national network. Comparable to Dolphin across Hep C, HIV, and immunology specialty categories, with broader therapeutic coverage and integrated payer/Caremark reach.
• Optum Specialty Pharmacy: Specialty pharmacy operated by Optum (UnitedHealth Group) delivering specialty medications, prior-authorization support, and value-based care services to payer and provider clients. Comparable to Dolphin in offering payer-side formulary management and specialty adherence, with much greater national scale and capital.
• Walgreens Specialty Pharmacy: Specialty pharmacy division of Walgreens Boots Alliance providing specialty drug dispensing, financial assistance, and adherence support nationwide. Comparable to Dolphin in Hep C and immunology dispensing, with the addition of extensive retail footprint and corporate-partner reach.

Direct peers

• US Bioservices: Specialty pharmacy providing specialty medications, patient adherence support, and provider-facing prior authorization services across multiple therapeutic areas. Comparable to Dolphin in the provider-anchored specialty dispensing model and adherence/value-based care positioning.
• Trellis Rx: Specialty pharmacy services company partnering with health systems and provider groups to deliver in-clinic specialty pharmacy and 340B programs. Directly comparable to Dolphin in integrating specialty pharmacy into provider workflows and capturing 340B savings for covered entities.
• Accredo (Express Scripts): Largest US specialty pharmacy operated by Evernorth/Express Scripts, dispensing specialty medications for complex and chronic conditions including Hepatitis C, HIV, and immunology. Directly comparable to Dolphin in dispensing Hep/Immunology therapies to payers, IPAs, and provider networks at much larger national scale.
• Avita Pharmacy: Specialty and 340B-focused pharmacy serving FQHCs, Ryan White clinics, and covered entities with specialty drug dispensing and 340B program management. Strongly comparable to Dolphin in 340B expertise, FQHC customer base, and Hep C / HIV clinical focus.
• PantherRx Rare: Specialty pharmacy focused on rare disease, complex therapies, and limited-distribution drugs including immunology and infectious disease. Comparable to Dolphin in specialty/limited-distribution dispensing and provider-relationship driven GTM, with a rare-disease specialization.
• BioPlus Specialty Pharmacy: Independent specialty pharmacy focused on complex conditions including Hepatitis C, HIV, and immunology, serving providers and patients across multiple states. Closely comparable to Dolphin in therapeutic focus and provider-anchored GTM, though larger and multi-state licensed.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dolphin Health Pharmacy